Lipidomic dissection of nonalcoholic steatohepatitis: moving beyond foie gras to fat traffic.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Dietary polyunsaturated fatty acids mediate the inverse association of stearoyl-CoA desaturase activity with the risk of fatty liver in dyslipidaemic individuals.European journal of nutrition · 2019
   Article
2. Translational approaches: from fatty liver to non-alcoholic steatohepatitis.World journal of gastroenterology · 2014
   Review
3. Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression.Journal of proteome research · 2012
   Article
4. NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications.Gut and liver · 2012
   Article
5. Farnesoid x receptor agonists: what they are and how they might be used in treating liver disease.Current gastroenterology reports · 2012
   Review
6. Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease.Journal of proteome research · 2010
   Article

Corrections and comments

• Commented on by
  Natural approach against lipotoxic traffic in nonalcoholic fatty liver disease.2010
• Comment on
  The plasma lipidomic signature of nonalcoholic steatohepatitis.2009

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as